Company intelligence / Profile preview

Prism Opportunity Fund

Needham, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Prism Opportunity Fund is a venture capital fund managed by Prism Ventures that focuses on early-stage investments within the healthcare and life sciences sectors. The fund typically targets companies developing innovative medical devices, specialty pharmaceuticals, and healthcare services. By providing both capital and strategic guidance, the fund aims to accelerate the commercialization of transformative medical technologies. Notable past investments include companies such as Trius Therapeutics and Amira Pharmaceuticals, reflecting a strong track record in the biotechnology and specialty drug space.

Industry: Investors

Beyond the preview

Go deeper on Prism Opportunity Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prism Opportunity Fund.

Explore the full profile